These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 14219458)

  • 1. FACTORS INFLUENCING THE CLINICAL USE OF CHELATES IN IRON STORAGE DISEASE.
    WEINER M
    Ann N Y Acad Sci; 1964 Oct; 119():789-96. PubMed ID: 14219458
    [No Abstract]   [Full Text] [Related]  

  • 2. METABOLISM OF IRON, CALCIUM AND MAGNESIUM IN HOMOZYGOUS THALASSEMIA.
    ERLANDSON ME; GOLUBOW J; WEHMAN J; SMITH CH
    Ann N Y Acad Sci; 1964 Oct; 119():769-75. PubMed ID: 14219456
    [No Abstract]   [Full Text] [Related]  

  • 3. CHELATING AGENTS IN THE DIAGNOSIS AND TREATMENT OF IRON OVERLOAD IN THALASSEMIA.
    SMITH RS
    Ann N Y Acad Sci; 1964 Oct; 119():776-88. PubMed ID: 14219457
    [No Abstract]   [Full Text] [Related]  

  • 4. EFFECT OF TRISODIUM CALCIUM DIETHYLENETRIAMINEPENTAACETATE ON BIVALENT CATIONS IN THALASSEMIA MAJOR.
    MULLER-EBERHARD U; ERLANDSON ME; GINN HE; SMITH CH
    Blood; 1963 Aug; 22():209-17. PubMed ID: 14045304
    [No Abstract]   [Full Text] [Related]  

  • 5. [DESFERRIOXAMINE (DF) AND DIETHYLENE TRIAMINE PENTA-ACETIC ACID TRISODIUM CALCIUM SALT (CA DTPA NA3) IN SIDEROSIS. 2].
    ALBAHARY C
    Presse Med (1893); 1965 Jan; 73():73-6. PubMed ID: 14234334
    [No Abstract]   [Full Text] [Related]  

  • 6. THE NEW CHELATING AGENT CA-DTPA IN THE TREATMENT OF PRIMARY HAEMOCHROMATOSIS.
    KEMBLE JV
    Guys Hosp Rep; 1964; 113():68-73. PubMed ID: 14114732
    [No Abstract]   [Full Text] [Related]  

  • 7. Myocardial iron loading in patients with thalassemia major in Turkey and the potential role of splenectomy in myocardial siderosis.
    Aydinok Y; Bayraktaroglu S; Yildiz D; Alper H
    J Pediatr Hematol Oncol; 2011 Jul; 33(5):374-8. PubMed ID: 21364469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iron excretion in thalassemia after the administration of chelating agents.
    Markum AH; Iskandar W; Keng KL; Odang O
    Paediatr Indones; 1969; 9(3):89-98. PubMed ID: 4981722
    [No Abstract]   [Full Text] [Related]  

  • 9. GROWTH OF CHLAMYDOMONAS MUNDANA IN THE PRESENCE OF DIFFERENT SYNTHETIC CHELATORS.
    MACIASR FM
    Appl Microbiol; 1964 Sep; 12(5):391-4. PubMed ID: 14215965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Metabolism and toxicity of therapeutic chelating agents. XII. Effect on DNA synthesis in crypt cells of rat intestine].
    Bohne F
    Strahlentherapie; 1972 Jan; 143(1):106-12. PubMed ID: 4625854
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical usefulness of iron chelating agents.
    Waxman HS; Brown EB
    Prog Hematol; 1969; 6():338-73. PubMed ID: 4976246
    [No Abstract]   [Full Text] [Related]  

  • 12. The cytotoxic interaction of inorganic trace elements with EDTA and cisplatin in sensitive and resistant human ovarian cancer cells.
    Maier RH; Purser SM; Nicholson DL; Pories WJ
    In Vitro Cell Dev Biol Anim; 1997 Mar; 33(3):218-21. PubMed ID: 9112132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CHELATION BY CALCIUM TRISODIUM PENTETATE IN WORKERS EXPOSED TO LEAD.
    BRUGSCH HG; COLOMBO NJ; PAGNOTTO LD
    N Engl J Med; 1965 May; 272():993-6. PubMed ID: 14279254
    [No Abstract]   [Full Text] [Related]  

  • 14. Combined long-term treatment of hemosiderosis with desferioxamine and DTPA in homozygous beta-thalassemia.
    Constantoulakis M; Economidou J; Karagiorga M; Katsantoni A; Gyftaki E
    Ann N Y Acad Sci; 1974; 232(0):193-200. PubMed ID: 4528481
    [No Abstract]   [Full Text] [Related]  

  • 15. BIVALENT CATIONS IN HOMOZYGOUS THALASSEMIA.
    ERLANDSON ME; GOLUBOW J; WEHMAN J; SMITH CH
    J Pediatr; 1965 Mar; 66():637-48. PubMed ID: 14264319
    [No Abstract]   [Full Text] [Related]  

  • 16. [CHANGES IN THE IRON CONTENT OF BLOOD AND URINE IN PATIENTS WITH LEAD POISONING TREATED WITH COMPLEXION THERAPY (PENTACIN--CANA3 DTPA)].
    DASHASH A
    Gig Tr Prof Zabol; 1964 Dec; 8():12-6. PubMed ID: 14306658
    [No Abstract]   [Full Text] [Related]  

  • 17. [Metabolism and toxicity of therapeutic chelating agents. I. Comparative studies on the excretion of EDTA and DTPA in the rat urine].
    Harmuth-Hoene AE
    Strahlentherapie; 1967 Sep; 134(1):110-22. PubMed ID: 4967657
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of orally administered chelating agents EDTA, DTPA and fructose on radioiron absorption in man.
    Davis PS; Deller DJ
    Australas Ann Med; 1967 Feb; 16(1):70-4. PubMed ID: 4962004
    [No Abstract]   [Full Text] [Related]  

  • 19. The influence of EDTA and DTPA present in urine samples on the alkaline phosphate precipitation.
    Valentin N
    Health Phys; 1966 Nov; 12(11):1633-4. PubMed ID: 4961667
    [No Abstract]   [Full Text] [Related]  

  • 20. Host-associated iron transfer factor in normal humans and patients with transfusion siderosis.
    Jones RL; Grady RW; Sorette MP; Cerami A
    J Lab Clin Med; 1986 May; 107(5):431-8. PubMed ID: 3701190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.